Inverse Folding & De Novo Backbone Generation
Acronym for: ProteinMPNN / RFdiffusion
Also known as: Fixed-Backbone Sequence Design, SE(3)-Equivariant Diffusion, De Novo Miniprotein Binders
A two-stage generative protein engineering model where an SE(3)-equivariant diffusion or flow-matching network first generates a novel 3D polypeptide backbone geometry tailored to a functional motif, followed by a graph message-passing neural network (Inverse Folding) that predicts amino acid sequences folding into that exact 3D backbone.
Architectural Role in Modern Life Science R&D
Forward protein folding (AlphaFold2, Boltz-1) maps sequence to structure (1D -> 3D). Protein design requires solving the inverse problem (3D -> 1D): given a desired catalytic active site or target receptor interface, what sequence will fold into a stable scaffold presenting that geometry? Before deep learning, Rosetta 물리 (physics) design required millions of CPU hours and suffered wet-lab expression success rates below 1%. Pairing RFdiffusion or Chroma (for 3D backbone generation) with ProteinMPNN or LigandMPNN (for inverse folding) raises soluble E. Coli expression and monomeric folding success rates above 50%, with crystal structures matching design models within 1.0 Angstrom RMSD. Why does this matter for your lab? If you're scaling Inverse Folding & De Novo Backbone Generation in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.
Evaluation & Wet-Lab Integration Checklist
How do you evaluate Inverse Folding & De Novo Backbone Generation without wasting six months? Start small. When we audit R&D informatics teams, we tell you to test three things first: prospective wet-lab accuracy (like SPR or Cryo-EM), native API sync with your ELN, and containerized GPU costs. Don't skip the retrospective benchmark. It's the fastest way to see if a vendor's model actually works on your proprietary targets.
Context
Forward protein folding (AlphaFold2, Boltz-1) maps sequence to structure (1D -> 3D). Protein design requires solving the inverse problem (3D -> 1D): given a desired catalytic active site or target receptor interface, what sequence will fold into a stable scaffold presenting that geometry? Before deep learning, Rosetta 물리 (physics) design required millions of CPU hours and suffered wet-lab expression success rates below 1%. Pairing RFdiffusion or Chroma (for 3D backbone generation) with ProteinMPNN or LigandMPNN (for inverse folding) raises soluble E. Coli expression and monomeric folding success rates above 50%, with crystal structures matching design models within 1.0 Angstrom RMSD. Why does this matter for your lab? If you're scaling Inverse Folding & De Novo Backbone Generation in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.
Examples
- 1Designing picomolar de novo miniprotein binders against parathyroid hormone receptor using RFdiffusion and ProteinMPNN, validated by X-ray crystallography at 0.8 Angstrom backbone RMSD.
- 2Using LigandMPNN to redesign the substrate-binding pocket of a transaminase enzyme around a non-natural chiral pharmaceutical intermediate for Codexis biocatalysis.
- 3Scaffolding a respiratory syncytial virus (RSV) neutralization epitope into a thermostable de novo vaccine immunogen.
Implementing Agents
AI agents that implement or utilize Inverse Folding & De Novo Backbone Generation:
Xaira Therapeutics
Commercializes RFdiffusion, ProteinMPNN, and LigandMPNN workflows pioneered at the University of Washington IPD.
Commercializes RFdiffusion, ProteinMPNN, and LigandMPNN workflows pioneered at the University of Washington IPD.
Arzeda
Combines physics-based Rosetta/diffusion design and inverse folding to engineer industrial enzymes at scale.
Combines physics-based Rosetta/diffusion design and inverse folding to engineer industrial enzymes at scale.
Codexis
Applies computational inverse folding and CodeEvolver directed evolution to manufacture pharmaceutical biocatalysts.
Applies computational inverse folding and CodeEvolver directed evolution to manufacture pharmaceutical biocatalysts.
Common Industries
Related Terms
Learn More
Verified References & Citations (2)
- [1]
Solid deep learning-based protein sequence design using ProteinMPNN rescues previously failed Rosetta designs.
- [2]
Atomic context-conditioned protein sequence design using LigandMPNN for small molecules, nucleotides, and metals.